Across TCGA pan-cancer cohorts, RNU6-808P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU6-808P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RNU6-808P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-808P is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KICH, HNSC, and CHOL are the cancer types where RNU6-808P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-808P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Male	All	−0.297	.002	5	view →
HNSC	Male	II,III,IV	+0.103	.045	3	view →
CHOL	All	All	+0.550	.025	1	view →
STAD	Male	All	+0.411	.031	1	view →
THCA	All	All	−0.208	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNU6-808P RNA expression & survival · all RNU6-808P data types